BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

227 related articles for article (PubMed ID: 24175253)

  • 1. Proton pump inhibitor-induced hypomagnesemia: A new challenge.
    Florentin M; Elisaf MS
    World J Nephrol; 2012 Dec; 1(6):151-4. PubMed ID: 24175253
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton pump inhibitor-induced hypomagnesemia complicated with serious cardiac arrhythmias.
    Chrysant SG
    Expert Rev Cardiovasc Ther; 2019 May; 17(5):345-351. PubMed ID: 31092056
    [No Abstract]   [Full Text] [Related]  

  • 3. Multiple electrolyte disorders triggered by proton pump inhibitor-induced hypomagnesemia: Case reports with a mini-review of the literature.
    Souza CC; Rigueto LG; Santiago HC; Seguro AC; Girardi AC; Luchi WM
    Clin Nephrol Case Stud; 2024; 12():6-11. PubMed ID: 38222324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Persistent severe hypomagnesemia caused by proton pump inhibitor resolved after laparoscopic fundoplication.
    Semb S; Helgstrand F; Hjørne F; Bytzer P
    World J Gastroenterol; 2017 Oct; 23(37):6907-6910. PubMed ID: 29085234
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hypomagnesemia and proton-pump inhibitors.
    Famularo G; Gasbarrone L; Minisola G
    Expert Opin Drug Saf; 2013 Sep; 12(5):709-16. PubMed ID: 23808631
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Proton-pump Inhibitor-induced Severe Hypomagnesemia and Hypocalcemia are Clinically Masked by Thiazide Diuretic.
    Uehara A; Kita Y; Sumi H; Shibagaki Y
    Intern Med; 2019 Aug; 58(15):2201-2205. PubMed ID: 30996187
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An approach to the diagnosis and management of a case presenting with recurrent hypomagnesemia secondary to the chronic use of a proton pump inhibitor.
    dos Santos LM; Guerra RA; Lazaretti-Castro M; Vieira JG; Portes Ede S; Dias-da-Silva MR
    Magnes Res; 2015 Dec; 28(4):136-45. PubMed ID: 26878253
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Proton pump inhibitor-associated hypomagnesemia: what do FDA data tell us?
    Luk CP; Parsons R; Lee YP; Hughes JD
    Ann Pharmacother; 2013 Jun; 47(6):773-80. PubMed ID: 23632281
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A case series of proton pump inhibitor-induced hypomagnesemia.
    Hoorn EJ; van der Hoek J; de Man RA; Kuipers EJ; Bolwerk C; Zietse R
    Am J Kidney Dis; 2010 Jul; 56(1):112-6. PubMed ID: 20189276
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Common single nucleotide polymorphisms in transient receptor potential melastatin type 6 increase the risk for proton pump inhibitor-induced hypomagnesemia: a case-control study.
    Hess MW; de Baaij JH; Broekman MM; Bisseling TM; Haarhuis BJ; Tan AC; Te Morsche RH; Hoenderop JG; Bindels RJ; Drenth JP
    Pharmacogenet Genomics; 2017 Mar; 27(3):83-88. PubMed ID: 27926584
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Relationship between long-term use of proton pump inhibitor (PPI) and hypomagnesemia in patients with gastroesophageal reflux disease.
    Arj A; Ghaleh Takizadeh Z; Gilassi H; Razavizadeh M
    Caspian J Intern Med; 2022; 13(1):107-112. PubMed ID: 35178215
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Severe Electrolyte Disturbances Due to Proton Pump Inhibitor Therapy: An Underrecognized Problem with Potentially Severe Sequelae.
    Tagboto S
    Am J Case Rep; 2022 Jul; 23():e936893. PubMed ID: 35836357
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Proton pump inhibitors and hypomagnesemia: a rare but serious complication.
    Perazella MA
    Kidney Int; 2013 Apr; 83(4):553-6. PubMed ID: 23538697
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Hypomagnesemia associated with a proton pump inhibitor.
    Matsuyama J; Tsuji K; Doyama H; Kim F; Takeda Y; Kito Y; Ito R; Nakanishi H; Hayashi T; Waseda Y; Tsuji S; Takemura K; Yamada S; Okada T; Kanaya H
    Intern Med; 2012; 51(16):2231-4. PubMed ID: 22892510
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton pump inhibitors and symptomatic hypomagnesemic hypoparathyroidism.
    Fatuzzo P; Portale G; Scollo V; Zanoli L; Granata A
    J Nephrol; 2017 Apr; 30(2):297-301. PubMed ID: 27206762
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence and risk factors of long-term proton pump inhibitors-associated hypomagnesemia: a cross-sectional study in hospitalized patients.
    Recart DA; Ferraris A; Petriglieri CI; Alonso Serena M; Bonella MB; Posadas-Martinez ML
    Intern Emerg Med; 2021 Apr; 16(3):711-717. PubMed ID: 33001349
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechanisms of proton pump inhibitor-induced hypomagnesemia.
    Gommers LMM; Hoenderop JGJ; de Baaij JHF
    Acta Physiol (Oxf); 2022 Aug; 235(4):e13846. PubMed ID: 35652564
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A Review of the Novel Application and Potential Adverse Effects of Proton Pump Inhibitors.
    Yu LY; Sun LN; Zhang XH; Li YQ; Yu L; Yuan ZQ; Meng L; Zhang HW; Wang YQ
    Adv Ther; 2017 May; 34(5):1070-1086. PubMed ID: 28429247
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment of hypomagnesemia.
    Ayuk J; Gittoes NJ
    Am J Kidney Dis; 2014 Apr; 63(4):691-5. PubMed ID: 24100128
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Risks and Benefits of Long-term Use of Proton Pump Inhibitors: Expert Review and Best Practice Advice From the American Gastroenterological Association.
    Freedberg DE; Kim LS; Yang YX
    Gastroenterology; 2017 Mar; 152(4):706-715. PubMed ID: 28257716
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.